Target intelligence / Profile preview

Ankyrin repeat and zinc finger peptidyl-tRNA hydrolase 1 (ANKZF1)

Target
ANKZF1
Molecular classification
Enzyme, Endonuclease, Zinc finger protein, Ankyrin repeat-containing protein
01

Overview

Ankyrin repeat and zinc finger peptidyl-tRNA hydrolase 1 (ANKZF1) is an endonuclease enzyme critical for protein quality control within the cell. It is responsible for cleaving polypeptidyl-tRNAs that are stalled on ribosomes during translation, a step crucial for ribosome-associated quality control (RQC)[1][2][3][4]. This cleavage event enables the release and subsequent degradation of incomplete and abnormal polypeptides, preventing the accumulation of defective proteins. ANKZF1's activity also generates tRNA fragments requiring repair before reuse in translation, and its function is linked to the cellular response to oxidative stress and maintenance of mitochondrial integrity[1][2][3][5]. ANKZF1 interacts with protein degradation networks (such as the p97/VCP ATPase system) and has been implicated in various pathological conditions, with altered expression associated with several cancers and rare mutations linked to inflammatory and immune-mediated diseases[3]. While it is emerging as a prospective therapeutic target, especially in oncology, there are currently no approved drugs or specific pharmacological modulators known for this protein[5].

Other names
tRNA endonuclease ANKZF1ZNF744FLJ10415Vms1Ankyrin repeat and zinc finger domain-containing protein 1Zinc finger protein 744ankyrin repeat and zinc finger domain containing 1
02

Biological functions

Protein quality controlRescue of stalled ribosometRNA cleavageCellular response to oxidative stressMaintenance of mitochondrial integrity
03

Disease associations

CancerInflammatory bowel diseaseImmune dysregulation diseases (e.g., spondyloenchondrodysplasia with immune dysregulation, chronic granulomatous disease)
04

Safety considerations

Potential safety concerns are not well characterizeddisruption of protein quality control may increase cellular stress or protein aggregation
05

Biomarkers

Potential for use in glycolysis-related risk signatures and cancer prognostic modelsnot a clinically validated biomarker

Beyond the preview

Go deeper on Ankyrin repeat and zinc finger peptidyl-tRNA hydrolase 1 (ANKZF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and zinc finger peptidyl-tRNA hydrolase 1 (ANKZF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call